Historical record - last NADAC effective date: 6/22/2016
Product Information
LEVALBUTEROL 1.25 MG/3 ML SOL is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.7405 per ML under NDC 43598040925. Its NADAC has been published 125 times since Feb 18, 2015.
FDA first approved this application on Dec 13, 2013. Its Orange Book therapeutic-equivalence code is AN.
Strength
1.25 mg/3mL
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598040925
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
6/22/2016
Active Ingredients
LEVALBUTEROLApproval Type
Generic (ANDA)
FDA Application
ANDA078171FDA Approved
12/13/2013
TE Code
AN
On Market Since
9/16/2014
Pharmacological Classes
Price Statistics
The NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has been published 125 times since Feb 18, 2015, and over the history we have for it it has declined 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7405 per ML |
|---|---|
| All-time high | $0.8611 (Mar 11, 2015) |
| All-time low | $0.6300 (Dec 23, 2015) |
| Median price | $0.7405 |
| Average price | $0.7440 |
| Largest weekly change | +21.9% (Jan 20, 2016) |
| Weeks tracked | 125 |
| Tracking since | Feb 18, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-14.0%
Last surveyed Jul 5, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levalbuterol inhalation 1.25mg/3mL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levalbuterol inhalation 1.25mg/3mL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVALBUTEROL 1.25 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL 1.25 MG/3 ML SOL, manufactured by Dr. Reddy's Laboratories Inc., is $0.7405 per ML (NDC 43598040925), effective Jul 5, 2017.
How has the price of LEVALBUTEROL 1.25 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has declined 14.0%. It has been tracked across 125 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for LEVALBUTEROL 1.25 MG/3 ML SOL?
Since Feb 18, 2015, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has ranged from a low of $0.6300 (Dec 23, 2015) to a high of $0.8611 (Mar 11, 2015), with a median of $0.7405 per ML.
Are there cheaper alternatives to LEVALBUTEROL 1.25 MG/3 ML SOL?
No other NADAC-published product currently shares the active ingredient and strength of LEVALBUTEROL 1.25 MG/3 ML SOL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVALBUTEROL 1.25 MG/3 ML SOL?
LEVALBUTEROL 1.25 MG/3 ML SOL (NDC 43598040925) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.